Cargando…
A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
BACKGROUND: Respiratory distress syndrome is the main cause of mortality and morbidity in preterm infants. “Less invasive surfactant administration” (LISA), which describes intratracheal surfactant administration to spontaneously breathing infants via a small diameter tube, is recommended as the fir...
Autores principales: | Göpel, Wolfgang, Rausch, Tanja K., Mitschdörfer, Barbara, Mader, Silke, Herting, Egbert, König, Inke R., Stichtenoth, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523706/ https://www.ncbi.nlm.nih.gov/pubmed/37752593 http://dx.doi.org/10.1186/s13063-023-07603-7 |
Ejemplares similares
-
Less invasive surfactant administration (LISA): chances and limitations
por: Herting, Egbert, et al.
Publicado: (2019) -
Less invasive surfactant administration: best practices and unanswered questions
por: Herting, Egbert, et al.
Publicado: (2020) -
Less invasive surfactant administration and complications of preterm birth
por: Härtel, Christoph, et al.
Publicado: (2018) -
Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study
por: Herting, Egbert, et al.
Publicado: (2020) -
Early Skin-to-Skin Contact Does Not Affect Cerebral Tissue Oxygenation in Preterm Infants <32 Weeks of Gestation
por: Hanke, Kathrin, et al.
Publicado: (2022)